about
Postgastrectomy polyneuropathy with thiamine deficiencyProgression and prognosis in pure autonomic failure (PAF): comparison with multiple system atrophy.Association between changes in visual evoked magnetic fields and non-motor features in Parkinson's disease.Beneficial biological effects and the underlying mechanisms of molecular hydrogen - comprehensive review of 321 original articles.The significance of carpal tunnel syndrome in transthyretin Val30Met familial amyloid polyneuropathy.Recovery of flow-mediated vasodilatation after repetitive measurements is involved in early vascular impairment: comparison with indices of vascular tone.An axonal form of Charcot-Marie-Tooth disease showing distinctive features in association with mutations in the peripheral myelin protein zero gene (Thr124Met or Asp75Val).Sjögren's syndrome associated painful sensory neuropathy without sensory ataxiaPrimary lateral sclerosis presenting parkinsonian symptoms without nigrostriatal involvement.Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson's Disease.Sweating dysfunctions in Parkinson's disease.Molecular hydrogen ameliorates several characteristics of preeclampsia in the Reduced Uterine Perfusion Pressure (RUPP) rat model.Association of leptin with orthostatic blood pressure changes in Parkinson's disease.Orthostatic hypotension caused by a localised dorsal medullary tumour.Erratum to: A randomized double-blind multi-center trial of hydrogen water for Parkinson's disease: protocol and baseline characteristics.Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status.Chronic inflammatory demyelinating polyneuropathy presenting with features of GBS.Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy.Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease.Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study.Distinct manifestation of cognitive deficits associate with different resting-state network disruptions in non-demented patients with Parkinson's disease.Severe hyposmia and aberrant functional connectivity in cognitively normal Parkinson's disease.Disinhibitory shift of recovery curve of somatosensory-evoked response in elderly: A magnetoencephalographic study.Recovery function of somatosensory evoked brain response in patients with carpal tunnel syndrome: A magnetoencephalographic study.Cortical and subcortical brain atrophy in Parkinson's disease with visual hallucination.Widespread cortical and subcortical brain atrophy in Parkinson's disease with excessive daytime sleepiness.Serum Tyrosine-to-Phenylalanine Ratio is Low in Parkinson's Disease.Relationship between respiratory failure and plasma noradrenaline levels in amyotrophic lateral sclerosis.Molecular hydrogen alleviates motor deficits and muscle degeneration in mdx mice.Noninvasive monitoring of plasma L-dopa concentrations using sweat samples in Parkinson's disease.Characteristic laryngoscopic findings in Parkinson's disease patients after subthalamic nucleus deep brain stimulation and its correlation with voice disorder.Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP.Clinical and Imaging Features of Multiple System Atrophy: Challenges for an Early and Clinically Definitive DiagnosisQuantification of hydrogen production by intestinal bacteria that are specifically dysregulated in Parkinson's diseaseAuditory brainstem responses in patients with autonomic failure with Parkinson's disease and multiple system atrophyClinical and physiological characteristics of autonomic failure with Parkinson's disease.Hyposmia and cardiovascular dysautonomia correlatively appear in early-stage Parkinson's disease.X-linked recessive bulbospinal neuronopathy. A clinicopathological studyTreatment of postprandial hypotension with selective alpha 1 and beta 1 adrenergic agonistsA scintigraphical qualitative analysis of peripheral vascular sympathetic function with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure
P50
Q28346307-0142DD54-1103-44B0-87EB-EC2DB4F3C730Q33152820-3B3D5EAD-E62B-467E-9B20-78A2FC9F979DQ33803870-6AF405DE-CB42-44A0-BC5F-EC6174611AECQ34674071-C06F6C50-528B-4BEC-904A-FC2ECEC0C753Q34993594-322277AE-FC6C-4570-8A54-459867313DC8Q35083294-57A8809D-89DF-4ECF-A78F-6140DA778551Q35460113-56DBE0B8-A7C5-4292-97B7-0138162AA89FQ35476207-7B71E1F3-9293-4570-BBD3-45F8D3FCF74AQ35478307-B25A5000-F121-4E13-BEA3-E1CB094F05BFQ35833353-710E5BF3-F04D-4B05-AB5E-2D010A88AC0DQ36666573-3369405C-3F91-4535-8604-93F16432F434Q38735744-A6173BD0-9CB1-4C08-8811-3B6BE2A3D95DQ38857542-078DF4BB-4A1C-4BD5-A010-4A4DEC1DA758Q41354259-963ABA06-E472-4B1A-8481-B303915A6F0EQ42320237-D73B8E72-A878-4DBA-A91E-EFCDDE8D9930Q43653458-6B155221-B101-4A65-94B3-D0583A77F0FCQ43933202-30267621-C5F0-4CAB-8C09-6713D7AA9E9FQ44499877-43259E27-C5FB-42B8-9797-35643DAD29F1Q46056285-E91F70C6-F703-4C77-B002-1F971F6807CFQ46270735-21089221-2A41-4C8C-8DD8-22721AF2058AQ47824693-874E357C-9BD7-42D0-9C90-89A8823336CCQ47881954-E6459213-68FB-4635-B8FD-9AED474B5BBCQ48435537-5ABD6EF9-7CBE-4C32-9D7B-17B7768A0C87Q48623526-D8C18486-8AF4-494E-9424-8CB225B1D8DFQ48917647-BB9DCDCF-3F2B-4AFF-A8B9-1D3AAE5FB0C4Q48944618-3CB016EA-A13C-42C9-9202-2EE475F8DE09Q50910862-4C20DA8F-F360-485B-AF2D-ACD3169951ADQ51573929-93F06F0B-093B-4867-954F-746CEBA645EEQ53180281-E8EED9FC-CB65-492E-ABAD-7C31B32E9016Q53337814-A8070242-C145-4A01-A6BD-18EBB2D59F32Q53386468-F6D16802-82BD-4B2A-AB8F-9998936F9161Q53859826-2EB8387A-3F10-48E6-8588-E22CB80E70C1Q58791873-F7325EAD-AD1B-46A6-9205-AF4D2BA4D56BQ60934114-8FE1F179-A151-44F4-8D52-E8DFE17B647FQ64819989-ED2FD526-92E5-4C01-82DE-657E24AA8FFDQ64856854-F0178EA1-E1B4-4621-93D8-FAC83D3E3E51Q64960552-C85C7F57-98A1-41BF-B7F8-4A85281F7519Q69947753-CA8A8DEB-ED93-4D27-A5C6-36D44B4E0553Q71605997-214944E4-6C0A-40D2-814C-DCE92923D5E3Q71746090-F3FDFD18-9825-41B7-80C8-B9FA578DF720
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-0092-7837
@en
name
Masaaki Hirayama
@ast
Masaaki Hirayama
@en
Masaaki Hirayama
@es
Masaaki Hirayama
@nl
type
label
Masaaki Hirayama
@ast
Masaaki Hirayama
@en
Masaaki Hirayama
@es
Masaaki Hirayama
@nl
altLabel
Hirayama M
@en
prefLabel
Masaaki Hirayama
@ast
Masaaki Hirayama
@en
Masaaki Hirayama
@es
Masaaki Hirayama
@nl
P1053
I-9341-2018
P106
P31
P4012
P496
0000-0003-0092-7837